The results of the latest clinical trial for Sanofi's new type 2 diabetes drug, LixiLan, exhibited positive results. With this, the pharmaceutical company is now preparing for regulatory reviews.
Sanofi's New Diabetes Drug LixiLan Shows Promising Results In Clinical Trial
Tech Times - 14 Sep 2015 15:05
The results of the latest clinical trial for Sanofi's new type 2 diabetes drug, LixiLan, exhibited positive results. With this, the pharmaceutical company is now preparing for regulatory reviews.
Share this Article
Recommended